top of page
SNC strip2.png

SNC'21 | LIVE

SiNAPSA Neuroscience Conference 2021

Logo-samokura2.png

PROGRAMME

Thursday, 23 September 2021

Opening of the SNC'21 | 13:45–14:00 

13:45–13:50  Maja Bresjanac

13:50–13:55  Blaž Koritnik

13:5514:00  Viktorija Radotič

Symposium | 14:00–16:00 

SARS-COV-2 AND BRAIN

Chair: Maja Bresjanac

14:00–14:30  Neuro-COVID - What it is and what it is not / Raimund Helbok

14:30–15:00  Neurological Associations of COVID-19 Vaccines / Jennifer Frontera

15:0015:30  Learning during the pandemic: mapping potential educational inequalities across Europe / Zsuzsa Blaskó

15:30–16:00  Cognitive and Neurological Consequences of COVID-19 / Adrian Owen

Symposium | 16:00–18:00 

METABOLIC BRAIN IMAGING IN NEURODEGENERATIVE DISORDERS Chair: Matej Perovnik and Maja Trošt

16:00–16:30  Mechanisms of tau pathology spreading in Alzheimer’s disease and 4R tauopathies / Nicolai Franzmeier

16:30–16:45  Developing and Interpreting a Deep Learning Model for Alzheimer’s Disease Tracking / Alison Deatsch

16:4517:00  Technical Factors Affecting Image Quality in PET / Mauro Namías

17:00–17:15  Cognition-related functional topographies in Parkinson’s disease: Localized loss of the ventral default mode network                         / Katharina A Schindlbeck

17:15–17:30  Metabolic correlates in PSP clinical subtypes / Gloria Martí-Andrés

17:3017:45  Specific Metabolic Brain Patterns in Alzheimer’s dementia and dementia with Lewy bodies / Matej Perovnik

17:45–18:00  Correlations between brain metabolism and neuropathology in sporadic Creutzfeldt-Jakob disease / Tomaž Rus

18:00–18:15  Break

Plenary talk | 18:15–19:00

CAN BRAIN IMAGING UNRAVEL THE TANGLED WEB OF NEURODEGENERATION? Thilo van Eimeren

Friday, 24 September 2021

Short Oral Presentations Session I | 11:00–12:00 

Dr. Janez Faganel Memorial lecture | 12:00–12:45 

SMALL FIBER NEUROPATHY Giuseppe Lauria

12:45–13:00  Break

Symposium | 13:00–14:30 

DEEP BRAIN STIMULATION FOR MOVEMENT DISORDERS - A NEUROIMAGING PERSPECTIVE

Chair: Maja Trošt and Dejan Georgiev

13:00–13.15  Non-motor symptoms in Parkinson's disease and Dystonia: Neuroimaging perspective / Vladimira Vuletić

13:15–13:30  The effect of Deep Brain Stimulation on Brain Metabolism in Movement Disorders / Maja Trošt

13:30–13:40  Parkinson's disease as a network disorder: Lessons from connectivity studies / Rok Berlot

13:40–13:50  Frequency modulation in deep brain stimulation: Does it work and is there neuroimaging proof of its action?

                      / Dejan Georgiev

13:50–14:00  Impulsivity in STN-DBS PD: More than a unitary phenomenon / Tjaša Mlinarič

14:0014:10  Effects of subthalamic nucleus deep brain stimulation on language in advanced Parkinson's disease / Živa Drakulić

14:1014:30  Discussion

14:30–15:00  Break

Workshop | 15:00–18:45 

EDUCATIONAL WORKSHOP ON CNS PROTEIN MISFOLDING

Chair: Lana Blinc

15:00–15:45 | Proteostasis Collapse: A Basis for Aging and Neurodegenerative Diseases / Richard I. Morimoto

15:45–16:15 | An update on Tau-related diseases / Gabor G. Kovacs

16:15–16:45 | TDP-43 proteinopathies / Boris Rogelj

16:45–17:15 | Now it is time for research to crack Parkinson’s disease / Patrik Brundin

17:15–17:45 | Huntington's disease / Roger A. Barker

17:45–18:15 | Transmissible Spongiform Encephalopathies / Adriano Aguzzi

18:15–18:45 | A structural biologist's view of neuroscience / Holger Wille

18:45–19:00  Break

AOŽ Memorial lecture | 19:00–19:45

GENETIC PRION DISORDERS AND PATIENT-SCIENTIST'S MANDATE Sonia M. Vallabh

Neuroscience and Society Dialogue | 19:45–20:30

Programme

Saturday, 25 September 2021

Short Oral Presentations Session II | 11:00–12:00

Plenary talk | 12:00–12:45 

SYSTEMS ALL THE WAY DOWN: STUDYING MENTAL HEALTH PROBLEMS AS BIOPSYCHOSOCIAL SYSTEMS Eiko Fried

12:45–13:00  Break

Symposium | 13:00–15:00 

MUSIC AND BRAIN: EVIDENCE-BASED MUSIC INTERVENTIONS IN MEDICINE

Chair: Igor M. Ravnik and Uroš Kovačič

13:00–13:30  Neurology of Music and Brain / Daniele Schoen

13:30–14:00  Research towards evidence-based music interventions / Stefan Koelsch

14:0014:30  The mother's voice, singing and speaking, as a special tool for early interventions in the NICU / Manuela Filippa

14:30–15:00  Heart rate variability in relation to self-selected music or music genres preselected by the researchers / Uroš Kovačič

Symposium | 15:00–17:00 

BRAIN HEALTH ACCROSS THE LIFESPAN  FINDINGS FROM THE LIFEBRAIN PROJECT

Chair: Isabelle Budin-Ljøsne

15:00–15:30  Ageing and brain imaging in Lifebrain / Klaus P. Ebmeier for Lifebrain Consortium

15:30–16:00  What can blood biomarkers tell us about the brain? / Christian A. Drevon

16:0016:30  What is brain health? Perceptions of respondents to the Global Brain Health Survey

                      / Isabelle Budin-Ljøsne for Lifebrain Consortium

16:30–17:00  Brain asymmetry in aging and Alzheimer's disease / James M. Roe

Plenary talk | 17:00–17:45

EXTRACELLULAR VESICLES AS STRESS SIGNALS: IDENTIFYING NOVEL MECHANISMS OF NEURODEVELOPMENTAL PROGRAMMING / Tracy Bale

SNC'21 Closing | 17:45–18:00 

17:45–18:00  Maja Bresjanac

SOP

Short Oral Presentations (Posters)

Short Oral Presentations (Posters)
Videtič Paska A: DNA methylation of BDNF and COMT candidate genes in Alzheimer's disease

Videtič Paska A: DNA methylation of BDNF and COMT candidate genes in Alzheimer's disease

06:22
Play Video
Ulbl J: The Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): standardisation  ...

Ulbl J: The Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): standardisation ...

04:38
Play Video
Roumpea G: Effect of repetitive transcranial magnetic stimulation on language performance ...

Roumpea G: Effect of repetitive transcranial magnetic stimulation on language performance ...

06:08
Play Video
Jan V: Expression on Na+,K+-ATPase isoenzymes and myokines in cultured human myotubes innervated ...

Jan V: Expression on Na+,K+-ATPase isoenzymes and myokines in cultured human myotubes innervated ...

06:45
Play Video
Ghosh D: HMGB1 inhibition attenuates lipopolysaccharide LPS induced neuroinflammation ...

Ghosh D: HMGB1 inhibition attenuates lipopolysaccharide LPS induced neuroinflammation ...

07:27
Play Video
Perovnik M: Educated vs. lay public view of neuroscience and science based brain health ...

Perovnik M: Educated vs. lay public view of neuroscience and science based brain health ...

06:51
Play Video
Pain P: Role of PDGFRα-Integrin interactions in Anoikis resistance mediated glioblastoma progression

Pain P: Role of PDGFRα-Integrin interactions in Anoikis resistance mediated glioblastoma progression

07:35
Play Video
Kuder A: Facilitation of the use of music in Slovene health care

Kuder A: Facilitation of the use of music in Slovene health care

07:25
Play Video

EXTENDED Q&A

In this section please find answers to the questions exceeding the available discussion time.

SARS-CoV-2 and Brain Symposium

For Prof. Raimund Helbok (Neuro-COVID: what it is and what it is not)

Q: Do any broadly accepted treatment options exist for persistent post-COVID olfactory dysfunction that does not resolve on its own?

A: No randomised controlled trial data available. Based on previous experience (viral diseases with hyposmia) smelling training can be tried, some observational studies show benefit. I would not recommend corticoid treatment althoug some countries/ENR doctors do so...

Q: Could be depression and anxiety associated with obligatory social isolation during acute phase of disease?

 

A: Sure, especially in patients with preexisting preclinical/clinical disorders.

 

Q: Are there gender differences in neurological consequences of Covid-19? 

A: Interesting question: in general, women do better, however, it seems that this is more true in hospitalized patients. We have seen that being a women is strongly associated with long term effects in non-hospitalized patients. 

Q: Have you spotted any differences in long term effects between those who were vaccinated before having been infected with Covid - and those who weren't? 

 

A: There are currently insufficient data to seriously answer this question, sorry. We are studying the variants now. 

Q: How can Slovenian neurologists join the EANcore?

 

A: Please, contact either me or the EAN using this Email: covidregistry@ean.org 

For Prof. Jennifer Frontera (Neurological Associations of COVID-19 Vaccines)

Q: Would you recommend classical protein vaccines more than novel ones (mRNA, DNA, ...)?

 

A: At this point the data on efficacy and safety of mRNA vaccines is very robust.  The nanoparticle vaccine Novavax also has promising data but there is much less real world experience with it at this point.  The mRNA vaccines appear to perform better than the adenovirus vaccines, though any vaccination is better than no vaccination.

 

Q: What pathologies are included in the »movement disorder« in your data? 

A: Movement disorder included primarily tremor, but also blepharospasm and dystonia were reported.